Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain
Dipeptidyl nitroalkenes are potent reversible inhibitors of cysteine proteases. Inhibitor 11 resulted to be the most potent one with Ki values of 0.49 and 0.44 nM against rhodesain and cruzain, respectively. According to enzymatic dilution and dialysis experiments, as well as computational and NMR s...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 21, 2016
|
| In: |
ACS medicinal chemistry letters
Year: 2016, Jahrgang: 7, Heft: 12, Pages: 1073-1076 |
| ISSN: | 1948-5875 |
| DOI: | 10.1021/acsmedchemlett.6b00276 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/acsmedchemlett.6b00276
|
| Verfasserangaben: | Antonio Latorre, Tanja Schirmeister, Jochen Kesselring, Sascha Jung, Patrick Johé, Ute A. Hellmich, Anna Heilos, Bernd Engels, R. Luise Krauth-Siegel, Natalie Dirdjaja, Lledó Bou-Iserte, Santiago Rodríguez, and Florenci V. González |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1700608436 | ||
| 003 | DE-627 | ||
| 005 | 20230426062149.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200615s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acsmedchemlett.6b00276 |2 doi | |
| 035 | |a (DE-627)1700608436 | ||
| 035 | |a (DE-599)KXP1700608436 | ||
| 035 | |a (OCoLC)1341339648 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Latorre, Antonio |e VerfasserIn |0 (DE-588)120989534X |0 (DE-627)1697820468 |4 aut | |
| 245 | 1 | 0 | |a Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain |c Antonio Latorre, Tanja Schirmeister, Jochen Kesselring, Sascha Jung, Patrick Johé, Ute A. Hellmich, Anna Heilos, Bernd Engels, R. Luise Krauth-Siegel, Natalie Dirdjaja, Lledó Bou-Iserte, Santiago Rodríguez, and Florenci V. González |
| 264 | 1 | |c September 21, 2016 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.06.2020 | ||
| 520 | |a Dipeptidyl nitroalkenes are potent reversible inhibitors of cysteine proteases. Inhibitor 11 resulted to be the most potent one with Ki values of 0.49 and 0.44 nM against rhodesain and cruzain, respectively. According to enzymatic dilution and dialysis experiments, as well as computational and NMR studies, dipeptidyl nitroalkenes are tightly binding covalent reversible inhibitors. | ||
| 700 | 1 | |a Schirmeister, Tanja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kesselring, Jochen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jung, Sascha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Johé, Patrick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hellmich, Ute A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heilos, Anna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Engels, Bernd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krauth-Siegel, Renate |e VerfasserIn |0 (DE-588)1050022335 |0 (DE-627)783217390 |0 (DE-576)404300200 |4 aut | |
| 700 | 1 | |a Dirdjaja, Natalie |e VerfasserIn |0 (DE-588)1100399550 |0 (DE-627)859361314 |0 (DE-576)469692405 |4 aut | |
| 700 | 1 | |a Bou-Iserte, Lledó |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rodríguez, Santiago |e VerfasserIn |4 aut | |
| 700 | 1 | |a González, Florenci V. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ACS medicinal chemistry letters |d Washington, DC : ACS, 2010 |g 7(2016), 12, Seite 1073-1076 |h Online-Ressource |w (DE-627)61638596X |w (DE-600)2532386-6 |w (DE-576)318518287 |x 1948-5875 |7 nnas |a Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain |
| 773 | 1 | 8 | |g volume:7 |g year:2016 |g number:12 |g pages:1073-1076 |g extent:4 |a Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain |
| 856 | 4 | 0 | |u https://doi.org/10.1021/acsmedchemlett.6b00276 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200615 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1100399550 |a Dirdjaja, Natalie |m 1100399550:Dirdjaja, Natalie |d 700000 |d 711000 |e 700000PD1100399550 |e 711000PD1100399550 |k 0/700000/ |k 1/700000/711000/ |p 10 | ||
| 998 | |g 1050022335 |a Krauth-Siegel, Renate |m 1050022335:Krauth-Siegel, Renate |d 700000 |d 711000 |e 700000PK1050022335 |e 711000PK1050022335 |k 0/700000/ |k 1/700000/711000/ |p 9 | ||
| 999 | |a KXP-PPN1700608436 |e 3687362051 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1021/acsmedchemlett.6b00276"],"eki":["1700608436"]},"origin":[{"dateIssuedDisp":"September 21, 2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Antonio Latorre, Tanja Schirmeister, Jochen Kesselring, Sascha Jung, Patrick Johé, Ute A. Hellmich, Anna Heilos, Bernd Engels, R. Luise Krauth-Siegel, Natalie Dirdjaja, Lledó Bou-Iserte, Santiago Rodríguez, and Florenci V. González"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2010","publisher":"ACS","dateIssuedDisp":"2010-","publisherPlace":"Washington, DC"}],"id":{"issn":["1948-5875"],"zdb":["2532386-6"],"eki":["61638596X"]},"name":{"displayForm":["American Chemical Society"]},"pubHistory":["1.2010 -"],"titleAlt":[{"title":"JMCLett"}],"part":{"text":"7(2016), 12, Seite 1073-1076","volume":"7","extent":"4","year":"2016","pages":"1073-1076","issue":"12"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzainACS medicinal chemistry letters","note":["Gesehen am 05.12.2018"],"language":["eng"],"recId":"61638596X","title":[{"title":"ACS medicinal chemistry letters","title_sort":"ACS medicinal chemistry letters"}]}],"physDesc":[{"extent":"4 S."}],"title":[{"title_sort":"Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain","title":"Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain"}],"person":[{"role":"aut","display":"Latorre, Antonio","roleDisplay":"VerfasserIn","given":"Antonio","family":"Latorre"},{"family":"Schirmeister","given":"Tanja","display":"Schirmeister, Tanja","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Kesselring","given":"Jochen","display":"Kesselring, Jochen","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Jung, Sascha","given":"Sascha","family":"Jung"},{"family":"Johé","given":"Patrick","display":"Johé, Patrick","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hellmich, Ute A.","given":"Ute A.","family":"Hellmich"},{"role":"aut","display":"Heilos, Anna","roleDisplay":"VerfasserIn","given":"Anna","family":"Heilos"},{"family":"Engels","given":"Bernd","display":"Engels, Bernd","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Krauth-Siegel, Renate","role":"aut","family":"Krauth-Siegel","given":"Renate"},{"roleDisplay":"VerfasserIn","display":"Dirdjaja, Natalie","role":"aut","family":"Dirdjaja","given":"Natalie"},{"display":"Bou-Iserte, Lledó","roleDisplay":"VerfasserIn","role":"aut","family":"Bou-Iserte","given":"Lledó"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Rodríguez, Santiago","given":"Santiago","family":"Rodríguez"},{"given":"Florenci V.","family":"González","role":"aut","roleDisplay":"VerfasserIn","display":"González, Florenci V."}],"language":["eng"],"recId":"1700608436","note":["Gesehen am 15.06.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a LATORREANTDIPEPTIDYL2120 | ||